US Patent Issued to Aardvark Therapeutics, The Spanish National Cancer Research Centre on Sept. 16 for "Combination therapies" (American, Spanish Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,934, issued on Sept. 16, was assigned to Aardvark Therapeutics Inc. (San Diego) and The Spanish National Cancer Research Centre (Madrid).

"Combination therapies" was invented by Daniel P. Gold (San Diego) and Miguel Quintela-Fandino (Madrid).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating and sensitizing cancer comprising administering a glycolytic inhibitor and an oxidative phosphorylation inhibitor."

The patent was filed on March 16, 2021, under Application No. 17/202,755.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=...